| Literature DB >> 35293054 |
Loren Brener1, Robyn Horwitz1, Jake Rance1, Theresa Caruana1, Joanne Bryant1.
Abstract
The COVID-19 pandemic has affected entire systems of health service provision globally, including health service closure, redeployment of staff and resources and implementation of infection prevention protocols. Harm reduction facilities face particular challenges responding to COVID-19, attempting to continue service provision to people who inject drugs with minimal service disruption whilst protecting their staff. This research assessed the impact of COVID-19 on staff working at harm reduction and alcohol and other drug (AOD) services in Australia in the first 9 months of the pandemic. The research employed mixed methods, using survey data to inform in-depth interviews. Surveys were completed by 207 participants working in the AOD sector and the harm reduction sector nationally. Interviews were conducted with 16 staff at three harm reduction sites in metropolitan Sydney and one regional NSW service. Staff felt able to respond to the trying circumstances of this pandemic, especially as practical messages around the COVID-19 response were similar to those already in place for clients in relation to blood-borne virus prevention. Staff felt that they were still able to provide core services to clients with some modifications in delivery. They were willing to take on additional responsibilities to ensure their own safety and that of clients, including conducting temperature checks and screening questions, whilst also adopting novel service provision strategies to reach clients during lockdowns such as postal services, outreach work and telehealth. NSP and AOD services were able to implement COVID-19 infection control strategies, whilst maintaining and expanding service access through remote and innovative strategies in a manner which supported both clients and service providers, during the first wave of the pandemic in 2020.Entities:
Keywords: COVID-19; drug treatment; harm reduction; health workers; people who use drugs
Year: 2022 PMID: 35293054 PMCID: PMC9111390 DOI: 10.1111/hsc.13782
Source DB: PubMed Journal: Health Soc Care Community ISSN: 0966-0410
Sociodemographic characteristics of the sample
|
| |
|---|---|
| Gender | |
| Male | 49 (24.5) |
| Female | 144 (72) |
| Transgender | 1 (0.5) |
| Non‐binary | 6 (3.0) |
| Age | |
| 18–29 | 22 (10.9) |
| 30–39 | 55 (27.4) |
| 40–49 | 55 (27.4) |
| 50–59 | 54 (26.9) |
| 60–69 | 15 (7.5) |
| Identity | |
| Aboriginal and Torres Strait Islander | 9 (4.5) |
| State | |
| NSW | 115 (57.2) |
| ACT | 5 (2.5) |
| Queensland | 16 (8.0) |
| South Australia | 4 (2.0) |
| Western Australia | 8 (4.0) |
| Victoria | 48 (23.9) |
| Tasmania | 5 (2.5) |
| Area | |
| Capital city (including surrounding suburbs) | 129 (64.5) |
| Regional city or town or remote area | 61 (30.5) |
| Rural area | 10 (5.0) |
| Place of work | |
| Pharmacotherapy providers | 9 (4.5) |
| Residential AOD | 19 (9.5) |
| Non‐residential AOD treatment service | 42 (20.9) |
| Needle and Syringe Program/Harm Reduction Program | 99 (49.3) |
| Other | 32 (15.9) |
| Duration of work in current role | |
| Less than one year | 31 (15.4) |
| 1–2 years | 52 (25.9) |
| 3–5 years | 50 (24.9) |
| 6–9 years | 22 (10.9) |
| 10 years or more | 46 (22.9) |
| Primary role | |
| Face‐to‐face service delivery | 127 (63.2) |
| Administration | 9 (4.5) |
| Management and face‐to‐face service delivery | 58 (28.9) |
| Other | 7 (3.5) |
| Employee status | |
| Full time | 127 (61.4) |
| Part time and fixed | 65 (31.4) |
| Casual or temporary | 15 (7.2) |
Alcohol and other drug services include treatment services such as residential rehabilitation, outpatient counselling and detoxification facilities.
Staff views on changes that have been implemented as a result of COVID
| Strongly disagree/disagree | Neither agree nor disagree | Strongly agree/agree | |
|---|---|---|---|
| Leadership has handled decisions around changes effectively | 22 (12.6) | 21 (12) | 132 (64.4) |
| Staff have been included in decisions about changes | 67 (38.3) | 26 (14.9) | 82 (46.8) |
| I struggled to work from home and found the changes to be isolating | 39 (39.8) | 32 (32.7) | 27 (27.6) |
| I felt supported by management in the transitioning to working from home | 19 (19) | 22 (22) | 59 (59) |
| I am unhappy with decision‐making by management around changes | 95 (55.5) | 29 (17) | 47 (27.4) |
| My role at work has changed quite substantially as a result of COVID‐19 | 51 (30.6) | 24 (14.4) | 92 (55) |
Staff perspective on changes in clients’ practices as a result of COVID
| Responses | |
|---|---|
| Clients are accessing face‐to‐face services less | 133 (64.3) |
| Clients are taking more needles and syringes | 81 (39.1) |
| Clients are drinking more alcohol | 70 (33.8) |
| Clients are using vending machines more | 55 (26.6) |
| Clients are using telehealth services more | 51 (24.6) |
| Clients are using/injecting more drugs | 39 (18.8) |
| Clients are taking more naloxone | 37 (17.9) |
| Clients are accessing the services more | 18 (8.7) |
| Clients are taking more water | 14 (6.8) |
| Clients are taking more spoons | 12 (5.8) |
| Clients are taking more filters | 9 (4.3) |
| Clients are sharing needles and syringes more often | 7 (3.4) |
Correlations with fear of COVID Scale
| Fears around working at service | |
|---|---|
| Fears around working at service | 1 |
| Gender | 0.154 |
| Age | −0.174 |
| Time in current role | −0.200 |
| More at risk because of where they work | 0.517 |
| Changes implemented enough to help clients | 0.246 |
| Scared of contracting COVID‐19 | −0.544 |
| Reduction in number of clients | 0.156 |
p < 0.05.
p < 0.01.
p < 0.001.